Topic: contract research organizations
Charles River has added another string to its early-stage R&D bow by acquiring preclinical services firm Citoxlab for $510 million in cash.
The revolving door of FDA staffers into the life science industry continues as four former executives at the U.S. regulator join the CRO’s ranks.
U.K.-based CRO Clinigen has bought the rights to Novartis’ Proleukin (aldesleukin) outside the U.S. as it looks to boost sales.
Clinipace is bringing on new members of its C-suite to build out its role as a midsized CRO, after appointing a new CEO last fall.
Syneos and Elligo will work together to recruit patients using EHRs and provide tools necessary for physicians to conduct research in their offices.
European CRO Optimapharm has expanded operations to the U.S., opening a new office in New York and appointing a VP for development in the Americas.
Admescope has acquired Swedish CRO MetaSafe, which focuses on metabolic research and drug biotransformation. Financial terms were not disclosed.
Icon signed an agreement with AG Mednet to use its electronic endpoint adjudication system to manage workflow and ensure data quality.
LabCorp acquired postmarket services provider Sciformix and plans to integrate it with Covance. The terms of the deal were not disclosed.
Syngene partnered with Zumutor to screen antigens against Zumutor’s human antibody libraries, to discover antibody clones for additional development.